Sleep-Disordered Breathing in Children with Prader-Willi Syndrome in Relation to Growth Hormone Therapy Onset

Maja Zimmermann1, Constanze Laemmer2, Joachim Woelfle3

  • 1Pediatric Endocrinology and Diabetology, Children's Hospital, University of Bonn, Bonn, Germany.

Insights

Early growth hormone (GH) therapy is safe for Prader-Willi syndrome (PWS) children with sleep apnea. Sleep apnea development in PWS children is independent of GH treatment onset, but regular sleep monitoring is recommended.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Genetics

Background:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder associated with various health issues, including sleep-related breathing disorders.
  • Obstructive sleep apnea (OSA) is a common comorbidity in children with PWS, impacting their growth and development.
  • The timing of growth hormone (GH) therapy initiation in relation to sleep apnea onset in PWS patients is not well-established.

Purpose of the Study:

  • To investigate the relationship between the age of initiating growth hormone (GH) therapy and the presence and severity of sleep apnea in children with Prader-Willi syndrome (PWS).
  • To assess the impact of early versus later GH therapy onset on key sleep apnea indices in PWS children.

Main Methods:

  • A longitudinal study analyzing cardiorespiratory polygraphy data from 62 PWS children, categorized into two groups based on GH therapy onset (before or after one year of age).
  • Sleep parameters including obstructive apnea hypopnea index (OAHI), central apnea index (CAI), oxygen desaturation index (ODI), and peripheral blood oxygen saturation (SpO2) were measured at baseline and at multiple time points post-GH therapy initiation.
  • Statistical analysis was performed to compare sleep apnea outcomes between the two treatment groups.

Main Results:

  • No significant differences in OAHI, CAI, ODI, or SpO2 were observed between PWS children who started GH therapy early versus later.
  • While pathological obstructive sleep apnea (OSA) increased in the early treatment group within the first three months, it normalized below baseline after one year in both groups.
  • The oxygen desaturation index (ODI) showed a significant decrease during GH therapy in both groups, indicating improvement in oxygenation.

Conclusions:

  • Obstructive sleep apnea in Prader-Willi syndrome children appears to develop independently of the timing of growth hormone therapy initiation.
  • Initiating GH therapy early in PWS children with sleep apnea is considered safe.
  • Regular sleep monitoring is crucial for PWS children undergoing GH therapy, regardless of treatment onset age.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
379
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.4K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
436
Respiratory Volumes and Capacities I01:26

Respiratory Volumes and Capacities I

Assessing the respiratory rate and rhythm for a complete minute is crucial for evaluating the breathing pattern. Even a minor increase in the patient's average respiratory rate, by as little as three to five breaths per minute, is an early and vital indicator of respiratory distress. Patients with a respiratory rate exceeding twenty-four breaths per minute require close monitoring to determine the physiological alterations. This careful observation is essential for prompt recognition and...
1.5K